In breast cancer, Dupouy et al. demonstrated that ER-positive NT-negative MCF-7 xenografts did not develop metastases, while NT-overexpressing clones developed metastases in 41% and 76% of cases for low- and high-NT-expressing clones, respectively [54]. Here, ESR1 is linked to breast cancer.